These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 16472590

  • 1. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease.
    Dring MM, Goulding CA, Trimble VI, Keegan D, Ryan AW, Brophy KM, Smyth CM, Keeling PW, O'Donoghue D, O'Sullivan M, O'Morain C, Mahmud N, Wikström AC, Kelleher D, McManus R.
    Gastroenterology; 2006 Feb; 130(2):341-8; quiz 592. PubMed ID: 16472590
    [Abstract] [Full Text] [Related]

  • 2. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J, Subrt I, Dìdek P, Siala K, Schwarz J, Machalová V, Varvarovská J, Pazdiora P, Pozler O, Stozický F.
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [Abstract] [Full Text] [Related]

  • 3. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
    Waller S, Tremelling M, Bredin F, Godfrey L, Howson J, Parkes M.
    Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
    [Abstract] [Full Text] [Related]

  • 4. Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease.
    Glas J, Seiderer J, Fischer D, Tengler B, Pfennig S, Wetzke M, Beigel F, Olszak T, Weidinger M, Göke B, Ochsenkühn T, Folwaczny M, Müller-Myhsok B, Diegelmann J, Czamara D, Brand S.
    Inflamm Bowel Dis; 2011 Sep; 17(9):1917-24. PubMed ID: 21830270
    [Abstract] [Full Text] [Related]

  • 5. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, Göke B, Folwaczny C, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [Abstract] [Full Text] [Related]

  • 6. Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease.
    Tosa M, Negoro K, Kinouchi Y, Abe H, Nomura E, Takagi S, Aihara H, Oomori S, Sugimura M, Takahashi K, Hiwatashi N, Takahashi S, Shimosegawa T.
    Scand J Gastroenterol; 2006 Jan; 41(1):48-53. PubMed ID: 16373276
    [Abstract] [Full Text] [Related]

  • 7. Nuclear pregnane X receptor single nucleotide polymorphism (-25385C/T) is not associated with inflammatory bowel disease in pediatric patients.
    Lacher M, Kappler R, Schroepf S, Berkholz S, Ballauff A, Bufler P, Baurecht H, von Schweinitz D, Koletzko S.
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):147-50. PubMed ID: 19516190
    [Abstract] [Full Text] [Related]

  • 8. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A, Palmieri O, Valvano MR, D'Incà R, Caprilli R, Cucchiara S, Sturniolo GC, Bossa F, Andriulli A, Annese V.
    Aliment Pharmacol Ther; 2008 Feb 01; 27(3):241-8. PubMed ID: 17944996
    [Abstract] [Full Text] [Related]

  • 9. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ, Nickerson P, Bernstein CN.
    Am J Gastroenterol; 2005 May 01; 100(5):1134-42. PubMed ID: 15842590
    [Abstract] [Full Text] [Related]

  • 10. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J, Konrad A, Schmechel S, Dambacher J, Seiderer J, Schroff F, Wetzke M, Roeske D, Török HP, Tonenchi L, Pfennig S, Haller D, Griga T, Klein W, Epplen JT, Folwaczny C, Lohse P, Göke B, Ochsenkühn T, Mussack T, Folwaczny M, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2008 Mar 01; 103(3):682-91. PubMed ID: 18162085
    [Abstract] [Full Text] [Related]

  • 11. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
    Glas J, Stallhofer J, Ripke S, Wetzke M, Pfennig S, Klein W, Epplen JT, Griga T, Schiemann U, Lacher M, Koletzko S, Folwaczny M, Lohse P, Göke B, Ochsenkühn T, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2009 Jul 01; 104(7):1737-44. PubMed ID: 19455118
    [Abstract] [Full Text] [Related]

  • 12. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency.
    Castro-Santos P, Suarez A, López-Rivas L, Mozo L, Gutierrez C.
    Am J Gastroenterol; 2006 May 01; 101(5):1039-47. PubMed ID: 16573780
    [Abstract] [Full Text] [Related]

  • 13. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
    Wolfkamp SC, Verstege MI, Vogels EW, Meisner S, Verseijden C, Stokkers PC, te Velde AA.
    Eur J Gastroenterol Hepatol; 2012 Aug 01; 24(8):965-70. PubMed ID: 22664939
    [Abstract] [Full Text] [Related]

  • 14. DLG5 variants contribute to Crohn disease risk in a Canadian population.
    Newman WG, Gu X, Wintle RF, Liu X, van Oene M, Amos CI, Siminovitch KA.
    Hum Mutat; 2006 Apr 01; 27(4):353-8. PubMed ID: 16450402
    [Abstract] [Full Text] [Related]

  • 15. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.
    Vermeire S, Pierik M, Hlavaty T, Claessens G, van Schuerbeeck N, Joossens S, Ferrante M, Henckaerts L, Bueno de Mesquita M, Vlietinck R, Rutgeerts P.
    Gastroenterology; 2005 Dec 01; 129(6):1845-53. PubMed ID: 16344053
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases.
    Saibeni S, Spina L, Virgilio T, Folcioni A, Borsi G, de Franchis R, Cugno M, Vecchi M.
    Eur J Gastroenterol Hepatol; 2007 Nov 01; 19(11):976-81. PubMed ID: 18049167
    [Abstract] [Full Text] [Related]

  • 17. [The significance of IL-13 gene +2044G/A mutation in patients with inflammatory bowel disease].
    Waterman M, Karban A, Nesher S, Weiss B, Shamir R, Eliakim R.
    Harefuah; 2006 Nov 01; 145(11):789-92, 864. PubMed ID: 17183946
    [Abstract] [Full Text] [Related]

  • 18. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease.
    Oostenbrug LE, Dijkstra G, Nolte IM, van Dullemen HM, Oosterom E, Faber KN, de Jong DJ, van der Linde K, te Meerman GJ, van der Steege G, Kleibeuker JH, Jansen PL.
    Scand J Gastroenterol; 2006 Oct 01; 41(10):1174-82. PubMed ID: 16990202
    [Abstract] [Full Text] [Related]

  • 19. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
    Petermann I, Huebner C, Browning BL, Gearry RB, Barclay ML, Kennedy M, Roberts R, Shelling AN, Philpott M, Han DY, Ferguson LR.
    Hum Immunol; 2009 Jun 01; 70(6):440-6. PubMed ID: 19275920
    [Abstract] [Full Text] [Related]

  • 20. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK, Oostenbrug LE, Nolte IM, Van Der Steege G, Oosterom E, Van Dullemen HM, Kleibeuker JH, Dijkstra G.
    Scand J Gastroenterol; 2007 Jul 01; 42(7):827-33. PubMed ID: 17558906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.